170398 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details p53
P53 ISOFORM VARIANT FOR DIAGNOSING CANCER
#2NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUNDS OF N-SULFONAMIDE AND USE THEREOF
#3p53 FRAGMENTS AS MARKERS FOR DIAGNOSIS AND PROGNOSIS OF NEURODEGENERATIVE DISEASE STATES
#4PHOSPHORYLATION OF P53 AS A PROGNOSTIC OR DIAGNOSTIC MARKER FOR THE TREATMENT OF SENESCENT CELLS IN A MAMMAL
#5DEVICE FOR DETECTION AND PROGNOSTIC ASSESSMENT OF NEURODEGENERATIVE DISORDERS
#6Combination Therapy to Treat Temperature Sensitive Mutant Tumors
#7P53 POST-TRANSLATIONAL MODIFICATIONS AS MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF A NEURODEGENERATIVE DISEASE
#8ANTIBODY BINDING A LINEAR EPITOPE OF HUMAN P53 AND DIAGNOSTIC APPLICATIONS THEREOF
#9USE OF ANTIGEN COMBINATION FOR DETECTING AUTOANTIBODIES IN LUNG CANCER
#10Methods and compositions for determining the functional activity of DNA double strand break repair pathway molecules for assessing germline risk of cancer
#11THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
#12T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53
#13THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
#14PROTECTION AGAINST STRESS-MEDIATED DAMAGE FROM IONIZING RADIATION
#15Antibody binding a linear epitope of human P53 and diagnostic applications thereof
#16p53 POST-TRANSLATIONAL MODIFICATIONS AS MARKERS IN THE DIAGNOSIS AND PROGNOSIS OF A NEURODEGENERATIVE DISEASE
#17Classification and Treatment of Gastric Cancer
#18METHODS FOR USE OF CDX2 AS A BIOMARKER TO GUIDE USE OF AUTOPHAGY INHIBITORS IN OVARIAN CANCER
#19Delta133P53Beta and Delta133P53Gamma isoforms are biomarkers of cancer stem cells
#20PANDA AS NOVEL THERAPEUTIC
#21Antibody binding a linear epitope of human P53 and diagnostic applications thereof
#22Antibody binding a linear epitope of human P53 and diagnostic applications thereof
#23Methods and compositions for assessing germline risk of cancer
#24Methods of treating cancer harboring hemizygous loss of TP53
#25HDM-2 TARGETING COMPOSITIONS CAUSE TUMOR CELL NECROSIS RATHER THAN APOPTOSIS OF CANCER CELLS
#26Protection against stress-mediated damage from ionizing radiation
#27Antibody binding a linear epitope of human p53 and diagnostic applications thereof
#28METHODS FOR TREATING CANCER
#29METHODS AND MATERIALS FOR MODULATING DEUBIQUITINASES AND UBIQUITINATED POLYPEPTIDES
#30Classification and Treatment of Gastric Cancer
#31Antibody binding a linear epitope of human p53 and diagnostic applications thereof
#32Methods of treating cancer harboring hemizygous loss of TP53
#33PUMA, A PRO-APOPTOTIC GENE, AS A NOVEL MOLECULAR BIOMARKER FOR TNFALPHA-INDUCED HUMAN ISLET DAMAGE
#34Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cells
#35THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER
#36Methods and compositions for assessing germline risk of cancer
#37PRMT5 inhibitors and uses thereof
#38Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (EMT) in cancer cells
#39Lung cancer adjuvant therapy
#40DD1ALPHA RECEPTOR AND USES THEREOF IN IMMUNE DISORDERS
#41Methods for breast cancer treatment
#42Protection against stress-mediated damage from ionizing radiation
#43Pharmaceutical combination comprising a CIP2A silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired P53 function
#44Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#45MARKERS ASSOCIATED WITH HUMAN DOUBLE MINUTE 2 INHIBITORS
#46Protection against apoptosis from ionizing radiation
#47Methods and materials for treating cancers that express reduced levels of wild-type p53 polypeptides
#48METHOD AND APPARATUS OF AIDING DETECTION OF SURFACE ABNORMALITY IN THE OESOPHAGUS
#49INTERFERON TREATMENT TARGETING MUTANT P53 EXPRESSING CELLS
#50Autoantibody Signature for the Early Detection of Ovarian Cancer
#51iASPP phosphorylation and metastatic potential
#52METHODS FOR DETERMINING RESISTANCE AGAINST MOLECULES TARGETING PROTEINS
#53Methods to predict progression of Barrett's Esophagus to high grade dysplasia esophageal adenocarcinoma
#54MEMBRANE RESIDENT PEPTIDE IN ANTI-CANCER PEPTIDES CAUSES TUMOR CELL NECROSIS RATHER THAN APOPTOSIS OF CANCER CELLS
#55Methods for screening inhibitors of tumor associated protein aggregation
#56MAPKAP kinase-2 as a specific target for blocking proliferation of P53-defective
#57P53 MODULATOR AND CANCER TARGET
#58Peptides and aptamers thereof as specific modulators of mutant p53 function
#59Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells
#60Response Prediction in Cancer Treatment Involving p53 Adapted Cancer Therapy
#61Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
#62METHOD FOR TESTING A SUBJECT THOUGHT TO BE PREDISPOSED TO HAVING METASTATIC CANCER USING DELTA133P53BETA
#63Downregulation of SPY1 by p53 as an essential component of p53-mediated effects
#64Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#65PUMA, a pro-apoptotic gene, as a novel molecular biomarker for TNFα-induced human islet damage
#66Method to rapidly identify critical p53 target genes that can be utilized for therapeutic intervention
#67Method of screening apoptosis accelerating compound or anti-apoptotic compound and method of determining malignancy of neurodegenerative disease
#68P53 modulator and cancer target
#69Modulating apoptosis
#70DNP63A gene and screening methods of anticancer agent by using it
#71Method for screening modulators of apoptosis
#72Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same
#73Method of evaluating or selecting agents for preventing or improving pigmented spots
#74Diagnostic panel of cancer antibodies and methods for use
#75Methods and compositions relating to promoter regulation by MUC1 and KLF proteins
#76Method for Detecting p53 Dysfunction, Method for Molecular Diagnosis of Cancer and Method for Evaluating Compound Effective in Treating Cancer
#77Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells
#78Selective and dual-action p53/MDM2/MDM4 antagonists
#79Methods and marker combinations for screening for predisposition to lung cancer
#80Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases
#81Modulating apoptosis